Am J Physiol Cell Physiol Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Cell Physiol 285: C39-C47, 2003. First published February 26, 2003; doi:10.1152/ajpcell.00461.2002
0363-6143/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/1/C39    most recent
00461.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Porter, M. J.
Right arrow Articles by Samarel, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Porter, M. J.
Right arrow Articles by Samarel, A. M.

RECEPTORS AND SIGNAL TRANSDUCTION

Isoenzyme-selective regulation of SERCA2 gene expression by protein kinase C in neonatal rat ventricular myocytes

Michael J. Porter,1 Maria C. Heidkamp,1 Brian T. Scully,1 Nehu Patel,1 Jody L. Martin,1,2 and Allen M. Samarel1,2

The Cardiovascular Institute and Departments of 1Medicine and 2Physiology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois 60153

Submitted 2 October 2002 ; accepted in final form 25 February 2003

Patients with cardiac hypertrophy and heart failure display abnormally slowed myocardial relaxation, which is associated with downregulation of sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2) gene expression. We previously showed that SERCA2 downregulation can be simulated in cultured neonatal rat ventricular myocytes (NRVM) by treatment with the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA). However, NRVM express three different PMA-sensitive PKC isoenzymes (PKC{alpha}, PKC{epsilon}, and PKC{delta}), which may be differentially regulated and have specific functions in the cardiomyocyte. Therefore, in this study we used adenoviral vectors encoding wild-type (wt) and kinase-defective, dominant negative (dn) mutant forms of PKC{alpha}, PKC{epsilon}, and PKC{delta} to analyze their individual effects in regulating SERCA2 gene expression in NRVM. Overexpression of wtPKC{epsilon} and wtPKC{delta}, but not wtPKC{alpha}, was sufficient to downregulate SERCA2 mRNA levels, as assessed by Northern blotting and quantitative, real-time RT-PCR (69 ± 7 and 61 ± 9% of control levels for wtPKC{epsilon} and wtPKC{delta}, respectively; P < 0.05 for each adenovirus; n = 8 experiments). Conversely, overexpression of all three dnPKCs appeared to significantly increase SERCA2 mRNA levels (dnPKC{delta} > dnPKC{epsilon} > dnPKC{alpha}). dnPKC{delta} overexpression produced the largest increase (2.8 ± 1.0-fold; n = 11 experiments). However, PMA treatment was still sufficient to downregulate SERCA2 mRNA levels despite overexpression of each dominant negative mutant. These data indicate that the novel PKC isoenzymes PKC{epsilon} and PKC{delta} selectively regulate SERCA2 gene expression in cardiomyocytes but that neither PKC alone is necessary for this effect if the other novel PKC can be activated.

heart; signal transduction; hypertrophy; transcription; mRNA stability; sarco(endo)plasmic reticulum Ca2+-ATPase


Address for reprint requests and other correspondence: A. M. Samarel, The Cardiovascular Institute, Loyola Univ. Medical Center, Bldg. 110, Rm. 5222, 2160 South First Ave., Maywood, IL 60153 (E-mail: asamare{at}lumc.edu).




This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
S. F. Steinberg
Structural Basis of Protein Kinase C Isoform Function
Physiol Rev, October 1, 2008; 88(4): 1341 - 1378.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger
Designing Heart Performance by Gene Transfer
Physiol Rev, October 1, 2008; 88(4): 1567 - 1651.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. L. Blum, A. M. Samarel, and R. Mestril
Phosphorylation and binding of AUF1 to the 3'-untranslated region of cardiomyocyte SERCA2a mRNA
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2543 - H2550.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
M. C. Heidkamp, B. T. Scully, K. Vijayan, S. J. Engman, E. L. Szotek, and A. M. Samarel
PYK2 regulates SERCA2 gene expression in neonatal rat ventricular myocytes
Am J Physiol Cell Physiol, August 1, 2005; 289(2): C471 - C482.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
K. Vijayan, E. L. Szotek, J. L. Martin, and A. M. Samarel
Protein kinase C-{alpha}-induced hypertrophy of neonatal rat ventricular myocytes
Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2777 - H2789.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
O. Zolk, F. Munzel, and T. Eschenhagen
Effects of chronic endothelin-1 stimulation on cardiac myocyte contractile function
Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1248 - H1257.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
P. Ping
A new chapter in cardiac PKC signaling studies: searching for isoform-specific molecular targets. Focus on: "Isoenzyme-selective regulation of SERCA2 gene expression by protein kinase C in neonatal rat ventricular myocytes"
Am J Physiol Cell Physiol, July 1, 2003; 285(1): C19 - C21.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.